AGP Picks
View all

Health & Wellness Today New York: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health & Wellness Today New York.

Press releases published on August 25, 2026

Acquisition of Own Shares
Inkoop van eigen aandelen
Spyre Therapeutics Announces Topline Results from the Rheumatoid Arthritis Sub-study of the SKYWAY Phase 2 Trial of SPY072
Ascendis Announces Oral Presentation of Week 104 Data from Its Pivotal Trial of TransCon® CNP (Navepegritide) at ISDS 2026
Incuvate Files Patent Infringement Lawsuit Against Penumbra
Global Veterinary Medical Devices Market to Reach $9.1 Billion by 2030, Driven by Rising Pet Ownership and Technological Innovation in Animal Healthcare
2026 Winners of the 32nd-Annual Eric Dostie Memorial College Scholarship Announced
BrewDog triumphiert bei den World Beer Awards 2026 mit herausragender Braukunst
BrewDog cumule les distinctions aux World Beer Awards 2026 et confirme l’excellence de son savoir-faire brassicole
Think Of Hydration Backpacks As Personal, Portable Hydration Stations To Help Workers Beat The Heat
AI Poised to Reshape Blood Cancer Therapeutics as Investment Surges Past $2 Billion Across Leading Biotech and Pharma Players
AI Disrupts the Optical Sorter Market as Billion-Dollar Investment Wave Targets Recycling Precision, Mining Efficiency, and Circular Economy Compliance
Le Fonds Rio Tinto Canada investit 2 millions de dollars pour faire avancer l’innovation en santé au Québec
Rio Tinto Canada Fund invests $2 million to advance healthcare innovation in Quebec
AI Is Reshaping Clinical Nutrition: Precision Therapy, Venture Capital, and the Food-as-Medicine Frontier
Allsup Explains What Workers With Chronic Pain Should Know About SSDI In 2026
Citizens Commission on Human Rights International Relaunches “Prescription for Violence” Documentary Amid Rising Concerns Over Psychotropic Drug-Induced Violence
New Jersey Social Media Legislation Brings Renewed Focus to Youth Mental Health
U.S. FDA Approves Ziihera® (zanidatamab-hrii) with and without Tislelizumab plus Chemotherapy in First-Line HER2+ Advanced Gastroesophageal Adenocarcinoma
Nika Pharmaceuticals, Inc. (OTCQB: NIKA) Funding Update

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Health & Wellness Today New York

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.